Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
The Relevance of REMAP-ILD for Ibero-American Countries: A Randomized Embedded Multifactorial Adaptive Platform (REMAP) Trial in the Field of Interstitial Lung Diseases (ILDs)
Leticia Kawano-Dourado; Maria Molina-Molina; Jacobo Sellares; Juan I. Enghelmayer;
Arch Bronconeumol. 2024;60:463-5
Peripheral Immune Cell Profiling Reveals Distinct Immune Hallmarks in Progressive Pulmonary Fibrosis
Fernanda Hernandez-Gonzalez; Nuria Mendoza; Sandra Casas-Recasens; Tamara Cruz; Nuria Albacar; Gemma López-Saiz; Xavier Alsina-Restoy; Mauricio Rojas; Alvar Agusti; Jacobo Sellarés; Rosa Faner;
Arch Bronconeumol. 2023;59:681-4
Highlights for the Clinical Practice in Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis: From the ATS/ERS/ALAT/JRS 2022 Guideline
Vanesa Vicens-Zygmunt; Maria Molina-Molina; Ganesh Raghu;
Arch Bronconeumol. 2023;59:73-5